For the quarter ending 2026-03-31, KALV has $328,917K in assets. $348,569K in debts. $213,768K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 213,768 | 229,342 | 243,497 | 124,304 |
| Marketable securities | 71,262 | 70,872 | 65,661 | 67,161 |
| Accounts receivable, net | 9,897 | 2,593 | 5,779 | 1,926 |
| Inventory | 4,002 | 3,428 | 458 | - |
| Research and development tax credit receivable | 7,430 | 6,200 | 1,343 | 561 |
| Prepaid expenses and other current assets | 7,846 | 7,712 | 8,488 | 11,944 |
| Total current assets | 314,205 | 320,147 | 325,226 | 205,896 |
| Property and equipment, net | 2,841 | 3,034 | 3,190 | 2,067 |
| Right of use assets | 9,421 | 9,825 | 9,096 | 5,165 |
| Other assets | 2,450 | 2,369 | 2,419 | 2,377 |
| Total assets | 328,917 | 335,375 | 339,931 | 215,505 |
| Accounts payable | 8,045 | 8,268 | 8,074 | 5,869 |
| Accrued expenses and other current liabilities | 34,022 | 33,897 | 20,767 | 18,971 |
| Deferred revenue - current portion | 833 | - | 11,512 | 11,413 |
| Lease liability - current portion | 1,691 | 1,621 | 1,429 | 2,122 |
| Royalty obligation - current portion | 16,226 | 13,569 | 3,287 | - |
| Total current liabilities | 60,817 | 57,355 | 45,069 | 38,375 |
| Deferred revenue - net of current portion | 21,357 | 11,714 | - | - |
| Lease liability - net of current portion | 10,411 | 10,727 | 9,128 | 4,019 |
| Royalty obligation - net of current portion | 116,583 | 119,063 | 129,707 | - |
| Royalty obligation | - | - | - | 132,321 |
| Convertible notes | 139,401 | 139,227 | 139,028 | - |
| Total long-term liabilities | - | - | - | 136,340 |
| Total liabilities | 348,569 | 338,086 | 322,932 | - |
| Common stock, 0.001 par value 100,000,000 shares authorized at march 31, 2026 and december 31, 2025 51,237,509 and 50,900,777 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 51 | 51 | 50 | 50 |
| Additional paid-in capital | 773,594 | 767,061 | 762,776 | 760,393 |
| Accumulated deficit | -786,181 | -762,694 | -739,098 | -713,266 |
| Accumulated other comprehensive loss | -7,116 | -7,129 | -6,729 | -6,387 |
| Total stockholders' deficit | -19,652 | -2,711 | 16,999 | 40,790 |
| Total liabilities and stockholders' deficit | 328,917 | 335,375 | 339,931 | 215,505 |
KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals, Inc. (KALV)